Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy.

Eschenhagen, Patience N; Bacher, Petra; Grehn, Claudia; Mainz, Jochen G; Scheffold, Alexander; Schwarz, Carsten

Eschenhagen, Patience N; Bacher, Petra; Grehn, Claudia; Mainz, Jochen G; Scheffold, Alexander; Schwarz, Carsten.

Afiliação

Eschenhagen PN; Cystic Fibrosis Section, Klinikum Westbrandenburg, Campus Potsdam, Potsdam, Germany.
Bacher P; HMU Health and Medical University, Potsdam, Germany.
Grehn C; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Mainz JG; Institute of Clinical Molecular Biology, Christian-Albrecht-University of Kiel, Kiel, Germany.
Scheffold A; Institute of Immunology, Christian-Albrecht-University of Kiel and UKSH Schleswig-Holstein, Kiel, Germany.
Schwarz C; Berlin Institute of Health at Charité Universitätsmedizin, Berlin, Germany.

Front Pharmacol ; 14: 1180826, 2023.

Article em En | MEDLINE | ID: mdl-37408761

Palavras-chave

Aspergillus fumigatus; Ki-67; Pseudomonas aeruginosa; antigen-specific T cells; cystic fibrosis; highly effective modulator therapy; total IgE; total IgG

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article